Establishment of a Vaginal Atrophy Rat Model and its Application in Pharmacodynamic Evaluation
ObjectiveTo establish an animal model suitable for screening vaginal preparations, administering the corresponding drugs, and evaluating biological indicators for monitoring drug treatment effects.MethodsBilateral ovariectomy (OVX) was used to establish the disease model of rat. The estrous cycle, u...
Main Authors: | YANG Liya, SONG Tao, HE Jialin, GUO Yiming, QI Mingkang, WANG Hanbi, WANG Huiping |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Laboratory Animal and Comparative Medicine
2022-12-01
|
Series: | Shiyan dongwu yu bijiao yixue |
Subjects: | |
Online Access: | https://www.slarc.org.cn/dwyx/CN/10.12300/j.issn.1674-5817.2022.014 |
Similar Items
-
Hyaluronic Acid and Radiofrequency in Patients with Urogenital Atrophy and Vaginal Laxity
by: Piotr Kolczewski, et al.
Published: (2022-12-01) -
Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use
by: Cagnacci A, et al.
Published: (2020-01-01) -
The role of topic vaginal products in posthysterectomy vaginal atrophy
by: Nicolae Bacalbasa, et al.
Published: (2021-09-01) -
Effect of Glycyrrhiza glabra vaginal cream on the mental symptoms of vaginal atrophy in postmenopausal women
by: Mastaneh Sadeghi, et al.
Published: (2018-06-01) -
Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause
by: Wurz GT, et al.
Published: (2014-11-01)